Incannex Healthcare Inc. IXHL
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.67% | -20.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -62.53% | -39.11% | |||
| Operating Income | 62.53% | 39.11% | |||
| Income Before Tax | 35.85% | 40.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 35.85% | 40.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 35.85% | 40.45% | |||
| EBIT | 62.53% | 39.11% | |||
| EBITDA | 63.19% | 39.56% | |||
| EPS Basic | 35.48% | 43.82% | |||
| Normalized Basic EPS | 35.47% | 43.84% | |||
| EPS Diluted | 35.48% | 43.82% | |||
| Normalized Diluted EPS | 35.47% | 43.84% | |||
| Average Basic Shares Outstanding | -0.56% | 6.01% | |||
| Average Diluted Shares Outstanding | -0.56% | 6.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||